Rigel Pharmaceuticals Inc (RIGL) returns
Rigel Pharmaceuticals returns over 10 years
$1,000 invested in Rigel Pharmaceuticals ten years ago was worth $1,981 at the close on October 30, 2026, with dividends reinvested: an average return of 7.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.6% | — | $1,066 | -0.9% |
| 3 months | +34.8% | — | $1,348 | +2.1% |
| Year to date | +19.8% | — | $1,198 | +11.7% |
| 1 year | +62.3% | — | $1,623 | +12.4% |
| 3 years | +557.5% | +87.3% | $6,575 | +88.5% |
| 5 years | +52.7% | +8.8% | $1,527 | +76.0% |
| 10 years | +98.1% | +7.1% | $1,981 | +316.6% |
Rigel Pharmaceuticals return by calendar year
| Year | RIGL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +19.8% | +11.7% | +8.1% |
| 2025 | +154.6% | +17.7% | +136.9% |
| 2024 | +16.0% | +24.9% | -8.9% |
| 2023 | -3.3% | +26.2% | -29.5% |
| 2022 | -43.4% | -18.2% | -25.2% |
| 2021 | -24.3% | +28.7% | -53.0% |
| 2020 | +63.6% | +18.4% | +45.2% |
| 2019 | -7.0% | +31.2% | -38.2% |
| 2018 | -40.7% | -4.6% | -36.2% |
| 2017 | +63.0% | +21.7% | +41.3% |
| 2016 | -21.5% | +12.0% | -33.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RIGL financials · RIGL valuation
No forecast, no recommendation. This page describes Rigel Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.